Related Experiment Video
Updated: Apr 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
DBC1 functions as a tumor suppressor by regulating p53 stability
Bo Qin1, Katherine Minter-Dykhouse2, Jia Yu2
1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433, China; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Abstract:
DBC1 (deleted in breast cancer 1), also known as CCAR2 or KIAA1967, is an important negative regulator of SIRT1 and cellular stress response. Although the Dbc1 gene localizes at a region that is homozygously deleted in breast cancer, its role in tumorigenesis remains unclear. It has been suggested to be either a tumor suppressor or an oncogene. Therefore, the function of DBC1 in cancer needs to be further explored. Here, we report that Dbc1 knockout mice are tumor prone, suggesting that DBC1 functions as a tumor suppressor in vivo. Our data suggest that the increased tumor incidence in Dbc1 knockout mice is independent of Sirt1. Instead, we found that DBC1 loss results in less p53 protein in vitro and in vivo. DBC1 directly binds p53 and stabilizes it through competition with MDM2. These studies reveal that DBC1 plays an important role in tumor suppression through p53 regulation.
Insights
Deleted in breast cancer 1 (DBC1) acts as a tumor suppressor by stabilizing p53 protein. DBC1 knockout mice show increased tumor susceptibility, highlighting its role in cancer prevention.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- DBC1 (deleted in breast cancer 1) is a gene located in a frequently deleted region in breast cancer.
- Its precise role in tumorigenesis is debated, with evidence suggesting it could be either a tumor suppressor or an oncogene.
- Understanding DBC1's function is crucial for cancer research.
Purpose of the Study:
- To investigate the in vivo function of DBC1 in cancer development.
- To elucidate the molecular mechanism by which DBC1 influences tumor suppression.
- To clarify the relationship between DBC1, SIRT1, and p53 in the context of cancer.
Main Methods:
- Generation and analysis of Dbc1 knockout mice to assess tumor incidence.
- In vitro and in vivo experiments to evaluate p53 protein levels and stability.
- Co-immunoprecipitation assays to determine the interaction between DBC1 and p53.
Main Results:
- Dbc1 knockout mice exhibited a strong predisposition to developing tumors, indicating DBC1's tumor suppressor role in vivo.
- The tumor-prone phenotype in knockout mice was independent of SIRT1.
- Loss of DBC1 led to decreased p53 protein levels, suggesting a regulatory role.
- DBC1 directly binds to p53 and enhances its stability by inhibiting MDM2-mediated degradation.
Conclusions:
- DBC1 functions as a critical tumor suppressor in vivo.
- DBC1 stabilizes p53 protein through direct interaction and competition with MDM2.
- These findings establish DBC1 as a key regulator of the p53 pathway in tumor suppression.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions

